生物药表征与CMC分析
…al evidence for structure, heterogeneity, potency, and comparability. HRMS Glycosylation Comparability Potency 工艺变更后，应如何组织可比性研究问题？ How should we frame comparability questions after a process change? 复杂蛋白的结构异质性需要哪些互补分析方法？ Which complementary methods help characterize a complex protein? 稳定性研究中的变化应如何与产…
生物药表征与CMC分析